925436-46-0

Basic information

• Product Name: 4-[[6-[2-[(2-QUINOXALINYLCARBONYL)AMINO]PHENYL]IMIDAZO [2,1-B]THIAZOL-3-YL]METHYL]-1-PIPERAZINECARBOXYLIC ACID 1,1-DIMETHYLETHYL ESTER
• Synonyms: tert-Butyl 4-((6-(2-(quinoxaline-2-carboxamido)phenyl)imidazo-[2,1-b]thiazol-3-yl)methyl)piper;4-[[6-[2-[(2-QUINOXALINYLCARBONYL)AMINO]PHENYL]IMIDAZO [2,1-B]THIAZOL-3-YL]METHYL]-1-PIPERAZINECARBOXYLIC ACID 1,1-DIMETHYLETHYL ESTER;1-Boc-4-[[6-[2-[(2-quinoxalinylcarbonyl)aMino]phenyl]iMidazo[2,1-b]thiazol-3-yl]Methyl]piperazine;tert-Butyl 4-((6-(2-(quinoxaline-2-carboxamido)phenyl)imidazo-[2,1-b]thiazol-3-yl)methyl)piperazi;tert-Butyl 4-((6-(2-(quinoxaline-2-carboxamido)phenyl)imidazo-[2,1-b]thiazol-3-yl)methyl)piperazine-1-carboxylate
• CAS NO: 925436-46-0
• Molecular Formula: C30H31N7O3S
• Molecular Weight: 569.67724
• Mol File: 925436-46-0.mol

Chemical Properties

• Appearance: /
• Density: 1.37±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 11.19±0.70(Predicted)
• CAS DataBase Reference: 4-[[6-[2-[(2-QUINOXALINYLCARBONYL)AMINO]PHENYL]IMIDAZO [2,1-B]THIAZOL-3-YL]METHYL]-1-PIPERAZINECARBOXYLIC ACID 1,1-DIMETHYLETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[[6-[2-[(2-QUINOXALINYLCARBONYL)AMINO]PHENYL]IMIDAZO [2,1-B]THIAZOL-3-YL]METHYL]-1-PIPERAZINECARBOXYLIC ACID 1,1-DIMETHYLETHYL ESTER(925436-46-0)
• EPA Substance Registry System: 4-[[6-[2-[(2-QUINOXALINYLCARBONYL)AMINO]PHENYL]IMIDAZO [2,1-B]THIAZOL-3-YL]METHYL]-1-PIPERAZINECARBOXYLIC ACID 1,1-DIMETHYLETHYL ESTER(925436-46-0)

Safety Data

• Hazardous Substances Data: 925436-46-0(Hazardous Substances Data)

Usage

Uses

Used in Medicinal Chemistry:
4-[[6-[2-[(2-quinoxalinylcarbonyl)amino]phenyl]imidazo[2,1-b]thiazol-3-yl]methyl]-1-piperazinecarboxylic acid 1,1-dimethylethyl ester is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique molecular structure and functional groups can be utilized to develop new drugs with improved therapeutic properties.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-[[6-[2-[(2-quinoxalinylcarbonyl)amino]phenyl]imidazo[2,1-b]thiazol-3-yl]methyl]-1-piperazinecarboxylic acid 1,1-dimethylethyl ester is used as a potential active pharmaceutical ingredient (API) for the development of new medications. Its complex structure and functional groups may contribute to its biological activity, making it a valuable component in the creation of innovative therapeutic agents.
Used in Drug Design and Optimization:
4-[[6-[2-[(2-quinoxalinylcarbonyl)amino]phenyl]imidazo[2,1-b]thiazol-3-yl]methyl]-1-piperazinecarboxylic acid 1,1-dimethylethyl ester is used as a starting point for drug design and optimization processes. Its molecular structure can be modified and fine-tuned to enhance its pharmacological properties, such as potency, selectivity, and bioavailability, leading to the development of more effective and safer drugs.
Used in Research and Development:
In research and development, 4-[[6-[2-[(2-quinoxalinylcarbonyl)amino]phenyl]imidazo[2,1-b]thiazol-3-yl]methyl]-1-piperazinecarboxylic acid 1,1-dimethylethyl ester serves as a valuable tool for studying the structure-activity relationships of various drug candidates. Its unique molecular features can provide insights into the design of new compounds with improved therapeutic potential.

Upstream product

• 6851-99-6 2-bromo-1-(2-nitrophenyl)ethanone 
• 1093403-37-2 C₁₃H₁₁N₃O₅S₂ 
• 912770-13-9 6-(2-nitro-phenyl)-imidazo[2,1-b]thiazole-3-carboxylic acid 
• 925437-84-9 6-(2-nitrophenyl)-imidazo[2,1-b]thiazole-3-carboxylic acid ethyl ester 
• 925437-85-0 (6-(2-nitrophenyl)imidazo[2,1-b]thiazol-3-yl)methanol 
• 54745-92-5 quinoxaline-2-carboxylic acid chloride 
• 925437-87-2 4-[6-(2-aminophenyl)imidazo[2,1-b]thiazol-3-ylmethyl]piperazine-1-carboxylic acid tert-butyl ester 

Downstream Products

• 925434-55-5 SRT1720 

Relevant articles and documents

Discovery of imidazo[1,2-6]thiazole derivatives as novel SIRT1 activators

A series of imidazo[1,2-b]thiazole derivatives is shown to activate the NAD+-dependent deacetylase SIRT1, a potential new therapeutic target to treat various metabolic disorders. This series of compounds was derived from a high throughput scree

SIRTUIN MODULATING IMIDAZOTHIAZOLE COMPOUNDS

Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

SIRTUIN POLYMORPHISMS AND METHODS OF USE THEREOF

Provided herein are methods for diagnosis and prognosis using polymorphic variants of sirtuins. Such polymorphic may be used, for example, to identify subjects that would be responsive to treatment with a sirtuin modulating compound andor subjects that are suffering from or susceptible to a disease mediated by a sirtuin. Also provided are methods for determining the predictive value of a sirtuin polymorphic variant, methods for evaluating sirtuin modulating compounds, and methods for determining appropriate dosage andor treatment regimens for subjects having one or more sirtuin polymorphic variants. Screening methods for identifying sirtuin modulating compounds using polymorphic variants of a sirtuin are also provided.